Abstract
The dose-related and time-related effects of vinblastine on tissue, platelet and plasma content of neuropeptide Y (NPY) were investigated in the rat and compared to the effects on catecholamine (CA) content. CA was quantified by HPLC with electrochemical detection and NPY-like immunoreactivity (LI) was analyzed by radioimmunoassay (RIA). Vinblastine (3.0 mg/kg, i.v.) decreased levels of both NPY-LI and CA after 48 h in the kidney, vas deferens and adrenal gland, whereas in the coeliac ganglion and bone marrow vinblastine induced an increase of NPY-LI which occurred already at a dose of 0.3 mg/kg. Also the content of NPY-LI in platelet-poor plasma and platelets as well as the decapitation-induced increase of plasma levels of noradrenaline (NA) and adrenaline (A) were attenuated by vinblastine (3.0 mg/kg). The elevation of NPY-LI content in the kidney, coeliac ganglion and bone marrow as well as the reduced levels of NPY-LI in platelets and platelet-poor plasma was observed already after 24 hours, whereas the reduction of NPY-LI and CA in the kidney and adrenal gland was present after 2 days. Vinblastine caused a biphasic effect on the content of NPY-LI in the sympathetic nerves of the kidney with an initial increase (by 120% at 24 h) followed by a decrease (by 79% at 4 days). The effect on NA-levels, however, was only a decrease. The axonal transport of NPY-LI as revealed by accumulation above a ligation of the sciatic nerve was reduced by 27% 2 days after vinblastine 3 mg/kg. The vinblastine-evoked depletion of NPY-LI and catecholamines in the kidney as well as in the adrenal was largely prevented by chlorisondamine, a nicotinic ganglionic blocking agent, suggesting that preganglionic neuronal activity was a key factor for this effect, in contrast to the influence on the coeliac ganglion cells and the megakaryocytes in the bone marrow. Furthermore, the delayed vinblastine depletion of NPY-LI in the kidney resembled the influence of surgical axotomy while reserpine caused a more rapid and complete depletion of both NPY-LI and NA. It is concluded that the multiple effects of vinblastine on sympathetic nerves, adrenal gland and megakaryocytes/thrombocytes can be monitored by analysis of NPY and be related to interference with microbutuli function and/or neuronal activation.
Similar content being viewed by others
References
G. Fried,Small noradrenergic storage vesicles isolated from rat vas deferens — biochemical and morphological characterization. Acta Physiol. Scand. Suppl.493, 1–28 (1980).
G. Fried, J. M. Lundberg and E. Theodorsson-Norheim,Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol. Scand.125, 145–154 (1985).
A. Dahlström and J. Häggendal,Intra-axonal transport of young amine granlues: implications for nerve terminal function. InCentral Nervous System — Studies on metabolic regulation and function (Eds. E. Genazzi and H. Hechen) pp. 94–103, Springer, Berlin (1973).
A. Dahlström,Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat. Europ. J. Pharmacol.5, 111–113 (1968).
A. Dahlström,Effects of vinblastine and colchicine on monoamine containing neurons of the rat with special regard to the axoplasmic transport of amine granules. Acta Neuropath. Suppl.5, 226–237 (1971).
M. E. Schwab and H. Thoenen,Mechanism of uptake and retrograde axonal transport of noradrenaline in sympathetic neurons in culture: reserpine-resistant large dense-core vesicles as transport vehicles. J. Cell Biol.96 (6), 1538–1547 (1983).
F. De Smet, F. Konings and W. De Potter,The effect of colchicine treatment on the bouyant density of noradrenaline storage particles in the rabbit superior cervical ganglion. Brain Res. 8,302, 335–338 (1984)
S. Brimioin,Transport and turnover of dopamine-beta-hydroxylase in sympathetic nerves of the rat. J. Neurochem.19, 2183–2193 (1972).
P. Keen and A. Livingston,Decline of tissue noradrenaline under the influence of a mitotic inhibitor. Nature227, 967–968 (1970).
D. L. Cheney, I. Hanin, R. Massarell, M. Trabucchi and E. Costa,Vinblastine and vincristine: a study of their action on tissue concentrations of epinephrine, norepinephrine and acetylcholine. Neuropharmacol.12, 233–238 (1973).
B. N. Dixit and C. A. Cubero,Characterization of vinblastine-induced supersensitivity in the rat J. Auton. Pharmacol.5, 31–39 (1985).
K. Unsicker, K. Limmeroth-Erwert, U. Otten, R. Lindmarf, K. Löffelholz and U. Wolf,Short- and long-term effects of vinblastine on the rat adrenal medulla. An ultrastructural and biochemical study. Cell Tissue Rev.196, 271–287 (1979).
A. F. Abrahamsen, O. Klepp, S. D. Fossa and A. Sönstevold,Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin. Scand. J. Haematol.37, 44–49 (1986).
P. J. Handagama, B. F. Feldman, N. C. Jain, T. B. Farver and C. S. Kono,In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents. Am. J. Vet. Res.48, 1142–1146 (1987).
J. M. Lundberg, A. Saria, A. Franco-Cereceda and E. Theodorsson-Norheim,Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. Acta Physiol. Scand.124, 603–611 (1985).
J. M. Lundberg, J. Pernow, A. Franco-Cereceda and A. Rudehill,Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y. J. Cardiovasc. Pharmacol.10, 551–568 (1987).
J. Pernow, P. Thorén, B.-I. Millberg and J. M. Lundberg,Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the rat. Acta Physiol. Scand.134, 53–59 (1988).
A. Eriksson, M. Schalling, K. McIntyre, J. M. Lundberg, D. Larhammer, K. Seroogy, T. Hökfelt and H. Persson,Detection of neuropeptide Y and its mRNA in megacaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. USA84, 5585–5589 (1987).
K. M. Myers, M. Y. Farhat, C. A. Vaz, H. R. Keiser and Z. Zukowska-Grojec,Release of immunoreactive neuropeptide Y by rat platelets. Biochem. Biophys. Res. Comm.155, 118–122 (1988).
E. Theodorsson-Norheim, A. Hemsén and J. M. Lundberg,Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand. J. Clin. Lab. Invest.45, 355–365 (1985).
P. Hjemdahl,Catecholamine measurements in plasma by high performance liquid chromatography with electrochemical detection. Methods Enzymol.142, 521–534 (1987).
E. Theodorsson-Norheim,Kruskal-Wallis test: basic computer program to perform non-parametric one-way analysis of variance and multiple comparisons on ranks of several independent values. Computer Programs Biomed.23, 57–62 (1986).
E. Gillespie, R. J. Levine and S. E. Malawista,Histamine release from rat peritoneal mast cells: Inhibition by colchicine and potentiation by deuterium oxide. J. Pharmacol. Exp. Ther.164, 158–165 (1968).
A. M. Poiser and J. Bernstein,A possible role of microtubules in catecholamine release from adrenal medulla: effect of colchicine, vinca alkaloids and deuterum oxide. J. Pharmacol. Exp. Ther.177, 102–108 (1971).
H. Kondo, H. Kuramoto and M. Yamamoto,Fine-structural localization of neuropeptide tyrosine (NPY)-like immunoreactivity in the neuronal somata of colchicine-pretreatment coeliac ganglia of rats. Cell Tissue Res.251 221–224 (1988).
J. M. Lundberg, G. Fried, J. Pernow and E. Theodorsson-Norheim,Corelease of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol. Scand.126, 231–238 (1986).
M. F. Roizen, J. Moss, D. P. Henry, V. Weise and I. J. Kopin,Effect of general anaesthetics on handling- and decapitation-induced increases in sympathoadrenal discharge. J. Pharmacol. Exp. Ther.204, 11–18 (1978).
Y. Yamamoto, H. Hasegawa, K. Iheda and A. Ichiyama,Cervical dislocation of mice induces rapid accumulation of platelet serotonin in the lung. Agents and Actions25, 48–56 (1988).
P. Klener, L. Donner and J. Huoskovà,Thrombocytosis in rats induced by vinblastine. Haemostasis1, 73–78 (1972).
M. Nagata, A. Franco-Cereceda, A. Saria, R. Amman and J. M. Lundberg,Reserpine-induced depletion of neuropeptide Y in the guinea-pig: tissue-specific effects and mechanism of action. J. Aut. Nerv. Syst.20, 257–263 (1987).
M. Schalling, A. Franco-Cereceda, T. Hökfelt, H. Persson and J. M. Lundberg,Increased neuropeptide Y messenger RNA and peptide in sympathetic ganglia after reserpine treatment. Europ. J. Pharmacol.156, 419–420 (1988).
G. Sedvall,Noradrenaline storage in skeletal muscle. Acta Physiol. Scand.64, 39–50 (1963).
M. Benmiloud and U. S. v. Euler,Effects of bretylium, reserpine, guanethidine and sympathetic denervation on the noradrenaline content of the rat submaxillary gland. Acta Physiol. Scand.59, 34–42 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hemsén, A., Pernow, J., Millberg, B.I. et al. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat. Agents and Actions 34, 429–438 (1991). https://doi.org/10.1007/BF01988740
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01988740